Clear Street's David Martin on institutional crypto collateral limits. Capital is segmented; a unified system is needed for TradFi/digital asset efficiency.
Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaidZymeworks to retain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results